Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 10;11(6):957.
doi: 10.3390/cells11060957.

New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides

Affiliations
Review

New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides

Ewa Mlyczyńska et al. Cells. .

Abstract

The corpus luteum is a small gland of great importance because its proper functioning determines not only the appropriate course of the estrous/menstrual cycle and embryo implantation, but also the subsequent maintenance of pregnancy. Among the well-known regulators of luteal tissue functions, increasing attention is focused on the role of neuropeptides and adipose tissue hormones-adipokines. Growing evidence points to the expression of these factors in the corpus luteum of women and different animal species, and their involvement in corpus luteum formation, endocrine function, angiogenesis, cells proliferation, apoptosis, and finally, regression. In the present review, we summarize the current knowledge about the expression and role of adipokines, such as adiponectin, leptin, apelin, vaspin, visfatin, chemerin, and neuropeptides like ghrelin, orexins, kisspeptin, and phoenixin in the physiological regulation of the corpus luteum function, as well as their potential involvement in pathologies affecting the luteal cells that disrupt the estrous cycle.

Keywords: adipokines; corpus luteum; luteinization; luteolysis; neuropeptides; progesterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Corpus luteum development, morphological and hormonal changes during the luteal phase. VEGF—vascular endothelial growth factor, FGF—fibroblast growth factor, ANG-1—angiopoietin 1, PCNA—proliferating cell nuclear antigen, p27Kip1—cyclin-dependent kinase inhibitor 1B, P4—progesterone, STAR—steroidogenic acute regulatory protein, CYP11A1—cytochrome P450 family 11 subfamily A member 1, HSD3B1—hydroxy-delta-5-steroid dehydrogenase, BCL-2—B-cell lymphoma-2 protein, PGE2—prostaglandin E2, PGF—prostaglandin F2α.
Figure 2
Figure 2
The influence of adipokines and neuropeptides on the functions of the corpus luteum in humans and various animal species. P4—progesterone, E2—estradiol, PGE2—prostaglandin E2, PGF—prostaglandin 2α, PTGER—prostaglandin E receptor, PTGFR—prostaglandin F re-ceptor, PCNA—proliferating cell nuclear antigen, VEGF—vascular endothelial growth factor, FGF2—fibroblast growth factor 2, ANG-1—angiopoietin 1, BCL-2—B-cell lymphoma-2 protein, BAX—Bcl-2-associated X protein, ↑—increase, ↓—decrease.
Figure 3
Figure 3
Involvement of adipokines and neuropeptides in corpus luteum pathology. P4—progesterone, LH—luteinizing hormone, ↓—decrease, ?—unknown effect.

Similar articles

Cited by

References

    1. Arosh J.A., Banu S.K., Chapdelaine P., Madore E., Sirois J., Fortier M.A. Prostaglandin biosynthesis, transport, and signaling in corpus luteum: A basis for autoregulation of luteal function. Endocrinology. 2004;145:2551–2560. doi: 10.1210/en.2003-1607. - DOI - PubMed
    1. Ricke W.A., Redmer D.A., Reynolds L.P. Growth and cellular proliferation of pig corpora lutea throughout the oestrous cycle. J. Reprod Fert. 1999;117:369–377. doi: 10.1530/jrf.0.1170369. - DOI - PubMed
    1. Bopp B., Shoupe D. Luteal phase defects. J. Reprod. Med. 1993;38:348–356. - PubMed
    1. Coomarasamy A., Williams H., Truchanowicz E., Seed P.T., Small R., Quenby S., Gupta P., Dawood F., Koot Y.E., Bender Atik R., et al. A randomized trial of progesterone in women with recurrent miscarriages. N. Eng. J. Med. 2015;373:2141–2148. doi: 10.1056/NEJMoa1504927. - DOI - PubMed
    1. Bowen-Shauver J.M., Gibori G. The corpus luteum of pregnancy. Ovary. 2014;4:201–230.

Publication types

LinkOut - more resources